Item Type | Name |
Concept
|
Male
|
Academic Article
|
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
|
Academic Article
|
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.
|
Academic Article
|
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
|
Academic Article
|
Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
|
Academic Article
|
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
The impact of topiramate on health-related quality of life indicators in chronic migraine.
|
Academic Article
|
Migraine prophylaxis with botulinum toxin A is associated with perception of headache.
|
Academic Article
|
Fremanezumab for the Preventive Treatment of Chronic Migraine.
|
Academic Article
|
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
|
Academic Article
|
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
|
Academic Article
|
Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.
|
Academic Article
|
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database.
|
Academic Article
|
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
|
Academic Article
|
Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders.
|
Academic Article
|
Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
|
Academic Article
|
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.
|
Academic Article
|
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
|
Academic Article
|
Hemicrania continua: an indomethacin-responsive case with an underlying malignant etiology.
|
Academic Article
|
Headache.
|
Academic Article
|
The Sinus, Allergy and Migraine Study (SAMS).
|
Academic Article
|
Atypical age-related cortical thinning in episodic migraine.
|
Academic Article
|
Adherence to oral migraine-preventive medications among patients with chronic migraine.
|
Academic Article
|
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
|
Academic Article
|
Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
|
Academic Article
|
Duration of migraine is a predictor for response to botulinum toxin type A.
|
Academic Article
|
Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.
|
Academic Article
|
Response to Letter to the Editor.
|
Academic Article
|
Tau Positron-Emission Tomography in Former National Football League Players.
|
Academic Article
|
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis.
|
Academic Article
|
CASE 1: the well-intentioned triptan prescriber.
|
Academic Article
|
Evaluation of cutaneous allodynia following induction of cortical spreading depression in freely moving rats.
|
Academic Article
|
Trial of Galcanezumab in Prevention of Episodic Cluster Headache.
|
Academic Article
|
Painful ophthalmoplegia: overview with a focus on Tolosa-Hunt syndrome.
|
Academic Article
|
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
|
Academic Article
|
Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
|
Academic Article
|
The role of digital subtraction myelography in the diagnosis and localization of spontaneous spinal CSF leaks.
|
Academic Article
|
A not so uncommon cause of thunderclap headache.
|
Academic Article
|
Site of effect of LY2951742 for migraine prophylaxis--authors' reply.
|
Academic Article
|
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
|
Academic Article
|
Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents.
|
Academic Article
|
Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage.
|
Academic Article
|
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
|
Academic Article
|
Fremanezumab for preventive treatment of migraine: Functional status on headache-free days.
|
Academic Article
|
Vascular safety of erenumab for migraine prevention.
|
Academic Article
|
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis.
|
Academic Article
|
Chronic daily headache: a rational approach to a challenging problem.
|
Academic Article
|
Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
|
Academic Article
|
The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients.
|
Academic Article
|
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.
|
Academic Article
|
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment.
|
Academic Article
|
Acute treatment and prevention of menstrually related migraine headache: evidence-based review.
|
Academic Article
|
Education and decision making at the time of triptan prescribing: patient expectations vs actual practice.
|
Academic Article
|
Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia.
|
Academic Article
|
Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial.
|
Academic Article
|
Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study.
|
Academic Article
|
Ubrogepant for the Treatment of Migraine.
|
Academic Article
|
Refractory headaches due to multilevel thoracic cerebrospinal fluid leaks.
|
Academic Article
|
Posttraumatic headache.
|
Academic Article
|
Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients.
|
Academic Article
|
Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM).
|
Academic Article
|
Identifying the factors underlying discontinuation of triptans.
|
Academic Article
|
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.
|
Academic Article
|
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
|
Academic Article
|
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
|
Academic Article
|
Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894.
|
Academic Article
|
Occipital nerve stimulator placement under general anesthesia: initial experience with 5 cases and review of the literature.
|
Academic Article
|
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
|
Academic Article
|
Prolonged neurologic complication and MRI abnormalities consequent to intracranial hypotension.
|
Academic Article
|
Stroke team remote evaluation using a digital observation camera in Arizona: the initial mayo clinic experience trial.
|
Academic Article
|
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
|
Academic Article
|
Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
|
Academic Article
|
Enhanced pain-induced activity of pain-processing regions in a case-control study of episodic migraine.
|
Academic Article
|
Sensitivity of MRI of the spine compared with CT myelography in orthostatic headache with CSF leak.
|
Academic Article
|
Tearing without pain after trigeminal root section for cluster headache.
|
Academic Article
|
Pearls: headache.
|
Academic Article
|
The effect of prophylactic medications on TMS for migraine aura.
|
Academic Article
|
Teleconcussion: an innovative approach to screening, diagnosis, and management of mild traumatic brain injury.
|
Academic Article
|
United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot Data.
|
Academic Article
|
Familial hemiplegic migraine: permanent attack-related neurologic deficits.
|
Academic Article
|
Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine.
|
Academic Article
|
A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
|
Academic Article
|
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
|
Academic Article
|
Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
|
Academic Article
|
55-Year-old man with thunderclap headache.
|
Academic Article
|
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.
|
Academic Article
|
Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study.
|
Academic Article
|
Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
|
Academic Article
|
The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade Students.
|
Academic Article
|
Triptan-induced latent sensitization: a possible basis for medication overuse headache.
|
Academic Article
|
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
|
Academic Article
|
Antimigraine efficacy of telcagepant based on patient's historical triptan response.
|
Academic Article
|
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial.
|
Academic Article
|
Comprehensive management of patients presenting to the otolaryngologist for sinus pressure, pain, or headache.
|
Academic Article
|
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points.
|
Academic Article
|
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
|
Academic Article
|
The headaches that awaken us.
|
Academic Article
|
Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based study.
|
Academic Article
|
Suboccipital steroid injections for cluster headache.
|
Academic Article
|
Triptan education and improving knowledge for optimal migraine treatment: an observational study.
|
Academic Article
|
Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headache.
|
Academic Article
|
BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial.
|
Academic Article
|
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.
|
Academic Article
|
Sub-classifying patients with mild traumatic brain injury: A clustering approach based on baseline clinical characteristics and 90-day and 180-day outcomes.
|
Academic Article
|
Activation of TRPA1 on dural afferents: a potential mechanism of headache pain.
|
Academic Article
|
Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.
|
Academic Article
|
Migraine: integrated approaches to clinical management and emerging treatments.
|
Academic Article
|
Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey study.
|
Academic Article
|
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.
|
Academic Article
|
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials.
|
Academic Article
|
Intractable SUNCT cured after resection of a pituitary microadenoma.
|
Academic Article
|
Narrative review: reversible cerebral vasoconstriction syndromes.
|
Academic Article
|
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.
|
Academic Article
|
Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?
|
Academic Article
|
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.
|
Academic Article
|
Blood pressure elevation in erenumab-treated patients with migraine: A retrospective real-world experience.
|
Academic Article
|
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
|
Academic Article
|
Association of Vascular Risk Factors and CSF and Imaging Biomarkers With White Matter Hyperintensities in Former American Football Players.
|
Academic Article
|
Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache.
|
Academic Article
|
Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project.
|
Academic Article
|
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine.
|
Academic Article
|
Hypersensitivity to BKCa channel opening in persistent post-traumatic headache.
|
Academic Article
|
Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial.
|
Academic Article
|
Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy (MOTS) trial.
|
Academic Article
|
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
|
Academic Article
|
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials.
|
Academic Article
|
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial.
|
Academic Article
|
A male-specific mechanism of meningeal nociceptor sensitization promoting migraine headache.
|
Academic Article
|
Olfactory function is reduced in a subset of former elite American football players with traumatic encephalopathy syndrome.
|
Academic Article
|
Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis.
|
Academic Article
|
Sex differences in effectiveness of CGRP receptor antagonism for treatment of acute and persistent headache-like pain in a mouse model of mild traumatic brain injury.
|
Academic Article
|
Chronification of migraine sensitizes to CGRP in male and female mice.
|